News

Photo of group of people standing in front of the U.S. Capitol Building

MIT Advocacy in Action at the AACR’s 2025 Hill Day

Koch Institute

MIT Koch Institute postdoc Meaghan McGeary traveled to Washington, DC to advocate for increased federal funding for cancer research as part of the annual American Association for Cancer Research (AACR) Hill Day. Joining other early-career scientists in a mission to make more than 50 congressional visits in a single day, she shared her experiences with policymakers, emphasizing the importance of stable research funding.  

Filter by

Filter by Title/Description

Filter by Topic

Filter by Year

Circular RNA Round-Up

Nature

Nature rounds up everything you need to know about circular RNA, including advances from the Anderson Lab and its spinout Orna Therapeutics. By tying ends of RNA together, circular RNA can stick around longer than the linear RNA currently used in vaccines and other therapies.

Moungi Bawendi wins 2023 Nobel Prize in Chemistry

MIT News

Congratulations to Moungi Bawendi, the Lester Wolfe Professor of Chemistry, on winning the 2023 Nobel Prize in Chemistry! Bawendi shares the prize with Louis Brus of Columbia University and Alexei Ekimov of Nanocrystals Technology for pioneering the development of quantum dots. These semiconducting nanocrystals emit exceptionally pure light and have been deployed in computer and television displays and biomedical imaging. Bawendi has collaborated with Koch Institute member Linda Griffith and former administrator W. David Lee ’69 on the Lumicell Imaging System, a low-cost single-cell imaging technology for eliminating residual cancer cells during tumor resection. Supported in its early stages of development by the Koch Institute Frontier Research Program through the Kathy and Curt Marble Cancer Research Fund, the system was pairs an injectable contrast agent with a hand-held, single-cell resolution imager to scan surgical margins for residual cancer cells. The system is now on the fast track to FDA approval, and could help eliminate the need for repeat cancer surgeries, reduce the incidence of relapse, and lower healthcare costs.

Targeting Titans of Transcription

MIT News

A signature technology from Angela Koehler is a low-cost screening tool for studying how transcription factors—proteins that regulate gene expression—interact with each other, and identifying compounds that modulate them. Beyond her lab, the platform contributes to translational work in her startup, Kronos Bio, which is now conducting clinical trials targeting MYC, a transcription factor whose dysregulation helps drive multiple cancers.

Blending Biology and AI

MIT News

Machine learning, AI and molecular biology come together for Yaffe Lab undergrad Charvi Sharma in Course 6-7, one of four new majors integrating data science with a second field. Sharma sees computer science and medicine dovetail through her work as an undergraduate researcher to understand how signaling pathways contribute to a cell’s ability to escape from cell cycle arrest after DNA damage. The data science and analysis skills she has honed through computer science courses help her understand and interpret the results of her research. She expects those same skills will prove useful in her future career as a physician.

Takara BioView Interviews Yadira Soto-Feliciano

Takara BioView Blog

Yadira Soto-Feliciano talks to Takara BioView, which celebrated National Hispanic Heritage Month with interviews Hispanic scientists who have made significant contributions to our understanding of health and disease. Her advice to young scientists is to embrace their identity, because “it’s bringing something different to the table—particularly in science which has historically been very homogeneous. It’s really important to bring people with accents, people that look different, people with different experiences, because that's where innovation will happen.”

Implantable Insulin Factory

MIT News

An implantable device from the Anderson and Langer Labs carries cells that produce insulin, plus a tiny oxygen-producing factory that keeps the cells healthy. The device, described in PNAS, could help control diabetes without the need for injections.

Anthrax Delivers

MIT News

Combining inspiration from nature with state-of-the-art machine learning and automation, the Pentelute Lab is inventing new chemistry platforms and techniques to develop therapies for cancer and beyond. To help solve biotechnology’s longstanding problem of delivering large and unwieldy molecules into cells, the lab hijacked the anthrax virus’s highly effective delivery system to transport antibody and peptide variants into cells to treat cancer.

Predicting Immunotherapy Response

MIT News

A Nature Genetics study from the Jacks Lab could help identify cancer patients who would benefit the most from immunotherapies called checkpoint blockade inhibitors. The researchers found in mouse models that measuring the diversity of mutations within a tumor generated much more accurate predictions of whether the treatment would succeed than measuring the overall number of mutations. If validated in clinical trials, this information could help doctors to better determine which patients will benefit from checkpoint blockade inhibitors.

Congratulations to the 2023 Amon Award Winners 

MIT Koch Institute

The Koch Institute at MIT is pleased to announce the winners of the 2023 Angelika Amon Young Scientist Award, Johanna Gassler (Max Planck Institute of Biochemistry, Germany) and Ruxandra-Andreea Lambuta (École Polytechnique Fédérale de Lausanne, Switzerland). Gassler and Lambuta, selected for their commitment to discovery science, will present their research at the Koch Institute on Thursday, November 2. 

New Medium Mimics Metabolism

MIT Koch Institute

Scientists often use human cancer cells grown in the lab to test potential anticancer drugs. Yet, the culture medium used in the lab does not accurately represent the nutrients present in the body, leading to discrepancies in drug responses. In a study published in Cell Chemical Biology, the Vander Heiden Laboratory has developed a new culture medium that better mimics physiological nutrient levels, supports the proliferation of diverse cancer cell lines and is amenable to high-throughput screening. The group found that drugs targeting cancer cell metabolism showed the most significant differences in effectiveness between standard cell culture medium and theirs. These findings may help researchers understand why some drugs that worked well in the lab fail in real-life situations and provides a new tool for screening potential anticancer agents, especially those targeting cancer cell metabolism.